Skip to ContentSkip to Navigation
How to find us L. Westerink, MSc

Publications

Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations

COST-EFFECTIVENESS OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (PF-ILD) IN THE NETHERLANDS